Literature DB >> 19671377

Autoimmunity in common variable immunodeficiency.

Shradha Agarwal1, Charlotte Cunningham-Rundles.   

Abstract

Common variable immunodeficiency (CVID) is the most common clinically significant primary immune defect. Although the hallmark of CVID is hypogammaglobulinemia, the intrinsic dysregulation of the immune system leads to defective T-cell activation and proliferation, as well as dendritic cell and cytokine defects. Although 70% to 80% of patients have had recurrent sinopulmonary infections, autoimmunity and inflammatory complications are also common. The most common autoimmune conditions are immune thrombocytopenic purpura and hemolytic anemia, but other autoimmune complications arise, including rheumatoid arthritis, pernicious anemia, primary biliary cirrhosis, thyroiditis, sicca syndrome, systemic lupus, and inflammatory bowel disease. Treatment of autoimmunity includes high-dose immunoglobulins, corticosteroids, selected immunosuppressants, and other immune modulators. This review focuses on autoimmune conditions associated with CVID, potential mechanisms of immune dysregulation, and therapeutic strategies.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19671377      PMCID: PMC2919211          DOI: 10.1007/s11882-009-0051-0

Source DB:  PubMed          Journal:  Curr Allergy Asthma Rep        ISSN: 1529-7322            Impact factor:   4.806


  50 in total

1.  Impaired antibody affinity maturation process characterizes a subset of patients with common variable immunodeficiency.

Authors:  D Bonhomme; L Hammarström; D Webster; H Chapel; O Hermine; F Le Deist; E Lepage; P H Romeo; Y Levy
Journal:  J Immunol       Date:  2000-10-15       Impact factor: 5.422

2.  Expansion of CD19(hi)CD21(lo/neg) B cells in common variable immunodeficiency (CVID) patients with autoimmune cytopenia.

Authors:  Klaus Warnatz; Claudia Wehr; Ruth Dräger; Sigune Schmidt; Hermann Eibel; Michael Schlesier; Hans-Hartmut Peter
Journal:  Immunobiology       Date:  2002-12       Impact factor: 3.144

3.  B cell differentiation defects in common variable immunodeficiency are ameliorated after stimulation with anti-CD40 antibody and IL-10.

Authors:  E M Eisenstein; K Chua; W Strober
Journal:  J Immunol       Date:  1994-06-15       Impact factor: 5.422

4.  Severe deficiency of switched memory B cells (CD27(+)IgM(-)IgD(-)) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease.

Authors:  Klaus Warnatz; Axel Denz; Ruth Dräger; Moritz Braun; Christoph Groth; Guido Wolff-Vorbeck; Hermann Eibel; Michael Schlesier; Hans Hartmut Peter
Journal:  Blood       Date:  2002-03-01       Impact factor: 22.113

5.  Classification of patients with common variable immunodeficiency by B cell secretion of IgM and IgG in response to anti-IgM and interleukin-2.

Authors:  A Bryant; N C Calver; E Toubi; A D Webster; J Farrant
Journal:  Clin Immunol Immunopathol       Date:  1990-08

Review 6.  Common variable immunodeficiency.

Authors:  C Cunningham-Rundles
Journal:  Curr Allergy Asthma Rep       Date:  2001-09       Impact factor: 4.806

7.  Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency.

Authors:  Bodo Grimbacher; Andreas Hutloff; Michael Schlesier; Erik Glocker; Klaus Warnatz; Ruth Dräger; Hermann Eibel; Beate Fischer; Alejandro A Schäffer; Hans W Mages; Richard A Kroczek; Hans H Peter
Journal:  Nat Immunol       Date:  2003-02-10       Impact factor: 25.606

Review 8.  Autoimmune thrombocytopenic purpura and common variable immunodeficiency: analysis of 21 cases and review of the literature.

Authors:  Marc Michel; Valérie Chanet; Lionel Galicier; Marc Ruivard; Yves Levy; Olivier Hermine; Eric Oksenhendler; Annette Schaeffer; Philippe Bierling; Bertrand Godeau
Journal:  Medicine (Baltimore)       Date:  2004-07       Impact factor: 1.889

9.  Reduced interleukin-2 (IL-2) production in common variable immunodeficiency is due to a primary abnormality of CD4+ T cell differentiation.

Authors:  E M Eisenstein; J S Jaffe; W Strober
Journal:  J Clin Immunol       Date:  1993-07       Impact factor: 8.317

10.  Long-term follow-up and outcome of a large cohort of patients with common variable immunodeficiency.

Authors:  Isabella Quinti; Annarosa Soresina; Giuseppe Spadaro; Silvana Martino; Simona Donnanno; Carlo Agostini; Pignata Claudio; Dammacco Franco; Anna Maria Pesce; Federica Borghese; Andrea Guerra; Roberto Rondelli; Alessandro Plebani
Journal:  J Clin Immunol       Date:  2007-02-14       Impact factor: 8.542

View more
  57 in total

1.  Multi-focal EBV-mucocutaneous ulcer heralding late-onset T-cell immunodeficiency in a woman with lupus erythematosus.

Authors:  Wing Y Au; Florence Loong; Thomas S K Wan; Antonio C K Tong
Journal:  Int J Hematol       Date:  2011-10-27       Impact factor: 2.490

2.  International Consensus Document (ICON): Common Variable Immunodeficiency Disorders.

Authors:  Francisco A Bonilla; Isil Barlan; Helen Chapel; Beatriz T Costa-Carvalho; Charlotte Cunningham-Rundles; M Teresa de la Morena; Francisco J Espinosa-Rosales; Lennart Hammarström; Shigeaki Nonoyama; Isabella Quinti; John M Routes; Mimi L K Tang; Klaus Warnatz
Journal:  J Allergy Clin Immunol Pract       Date:  2015-11-07

3.  IgH sequences in common variable immune deficiency reveal altered B cell development and selection.

Authors:  Krishna M Roskin; Noa Simchoni; Yi Liu; Ji-Yeun Lee; Katie Seo; Ramona A Hoh; Tho Pham; Joon H Park; David Furman; Cornelia L Dekker; Mark M Davis; Judith A James; Kari C Nadeau; Charlotte Cunningham-Rundles; Scott D Boyd
Journal:  Sci Transl Med       Date:  2015-08-26       Impact factor: 17.956

4.  Autoimmunity and asthma: The dirt on the hygiene hypothesis.

Authors:  Mark D Mannie
Journal:  Self Nonself       Date:  2010-02-15

5.  Defective functions of polymorphonuclear neutrophils in patients with common variable immunodeficiency.

Authors:  Sarah Casulli; Hélène Coignard-Biehler; Karima Amazzough; Michka Shoai-Tehrani; Jagadeesh Bayry; Nizar Mahlaoui; Carole Elbim; Srini V Kaveri
Journal:  Immunol Res       Date:  2014-10       Impact factor: 2.829

Review 6.  Common variable immune deficiency: Dissection of the variable.

Authors:  Charlotte Cunningham-Rundles
Journal:  Immunol Rev       Date:  2019-01       Impact factor: 12.988

7.  A missed opportunity.

Authors:  Ryan Van Wert; Ann Marie McKenna; Christopher A Smith; Peter Vadas; Allan S Detsky; Ophyr Mourad
Journal:  J Gen Intern Med       Date:  2012-11-13       Impact factor: 5.128

8.  Long-term follow-up on affinity maturation and memory B-cell generation in patients with common variable immunodeficiency.

Authors:  V Ballegaard; H Permin; T L Katzenstein; H V Marquart; L Schejbel
Journal:  J Clin Immunol       Date:  2013-05-07       Impact factor: 8.317

Review 9.  National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Immune Dysregulation and Pathobiology Working Group Report.

Authors:  Juan Gea-Banacloche; Krishna V Komanduri; Paul Carpenter; Sophie Paczesny; Stefanie Sarantopoulos; Jo-Anne Young; Nahed El Kassar; Robert Q Le; Kirk R Schultz; Linda M Griffith; Bipin N Savani; John R Wingard
Journal:  Biol Blood Marrow Transplant       Date:  2016-10-14       Impact factor: 5.742

10.  Nodular regenerative hyperplasia in common variable immunodeficiency.

Authors:  Ivan J Fuss; Julia Friend; Zhiqiong Yang; Jian Ping He; Lubna Hooda; James Boyer; Liqiang Xi; Mark Raffeld; David E Kleiner; Theo Heller; Warren Strober
Journal:  J Clin Immunol       Date:  2013-02-19       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.